Takeda Files Actos/Metformin Combination Actoplus Met For Type 2 Diabetes
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Takeda’s antidiabetic Actos/metformin combination Actoplus Met could be on the market by fall 2005, assuming a standard NDA review timeline.